The mechanism of Cangfu Daotan Decoction in polycystic ovary syndrome based on NEK7-NLRP3 inflammasome signaling pathway

Effect of Fasting on the NLRP3 Inflammasome

计划入组 23 人 · 首次发布于 2014 年 4 月 24 日

Role of NLRP3 in Periodontitis and Diabetes

计划入组 133 人 · 首次发布于 2020 年 6 月 30 日

NLRP3 antagonist

NMRA-NLRP3

exoASO-NLRP3

Ventyx Biosciences

United States

Halia Therapeutics Presents Phase II Data on HT-6184 for Post-Procedural Inflammation and Pain

Halia Therapeutics Completes Enrollment in Phase 2a Trial of Novel NLRP3 Inflammasome Inhibitor for Myelodysplastic Syndrome

Halia Therapeutics Initiates Phase 2a Trial of First-in-Class NLRP3 Inhibitor HT-6184 for Lower-Risk Myelodysplastic Syndromes